chr7-5481906-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_024963.6(FBXL18):​c.2026A>G​(p.Asn676Asp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

FBXL18
NM_024963.6 missense

Scores

3
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.89
Variant links:
Genes affected
FBXL18 (HGNC:21874): (F-box and leucine rich repeat protein 18) The protein encoded by this gene is a member of a family of proteins that contain an approximately 40-amino acid F-box motif. This motif is important for interaction with SKP1 and for targeting some proteins for degradation. The encoded protein has been shown to control the cellular level of FBXL7, a protein that induces mitotic arrest, by targeting it for polyubiquitylation and proteasomal degradation. Members of the F-box protein family, such as FBXL18, are characterized by an approximately 40-amino acid F-box motif. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19575378).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBXL18NM_024963.6 linkuse as main transcriptc.2026A>G p.Asn676Asp missense_variant 5/5 ENST00000382368.8 NP_079239.3 Q96ME1-4Q96D16
FBXL18NM_001367780.1 linkuse as main transcriptc.1726A>G p.Asn576Asp missense_variant 5/5 NP_001354709.1
FBXL18NM_001367781.1 linkuse as main transcriptc.1726A>G p.Asn576Asp missense_variant 5/5 NP_001354710.1
FBXL18NM_001363441.2 linkuse as main transcriptc.2000+9325A>G intron_variant NP_001350370.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBXL18ENST00000382368.8 linkuse as main transcriptc.2026A>G p.Asn676Asp missense_variant 5/55 NM_024963.6 ENSP00000371805.3 Q96ME1-4
FBXL18ENST00000415009.5 linkuse as main transcriptn.2000+9325A>G intron_variant 2 ENSP00000415064.1 Q96ME1-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 01, 2023The c.2026A>G (p.N676D) alteration is located in exon 5 (coding exon 5) of the FBXL18 gene. This alteration results from a A to G substitution at nucleotide position 2026, causing the asparagine (N) at amino acid position 676 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.028
T
BayesDel_noAF
Benign
-0.55
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.026
T
Eigen
Benign
0.091
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-1.1
T
Sift4G
Benign
0.38
T
Vest4
0.092
MVP
0.35
ClinPred
0.77
D
GERP RS
3.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-5521537; API